Related Experiment Video
Updated: Jan 4, 2026

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
Yeast models of neurodegenerative diseases
1Kent Fungal Group, School of Biosciences, University of Kent, Canterbury, United Kingdom.
Abstract:
The yeast Saccharomyces cerevisiae has been used to develop a wide range of highly tractable living models of the major human neurodegenerative diseases. Yet even though this microorganism lacks neuron-specific structures and processes, these models have provided new insights into the underlying disease mechanisms. Furthermore, they have allowed new therapeutic targets to be identified as well as providing a means of identifying potential therapeutic agents using high throughput cell-based screens. In this article, the benefits and limitations of S. cerevisiae-based neurodegenerative disease models are explored. Consideration is also given to future opportunities the exploitation of these models present, including the use of other yeast species such as Schizosaccharomyces pombe.
Insights
Yeast models, like Saccharomyces cerevisiae, offer valuable insights into human neurodegenerative diseases, aiding in the identification of therapeutic targets and agents. These models, despite lacking neurons, provide a powerful tool for disease research.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- The yeast Saccharomyces cerevisiae is a versatile model organism.
- Human neurodegenerative diseases pose significant research challenges.
- Developing tractable models is crucial for understanding disease mechanisms.
Purpose of the Study:
- To explore the benefits and limitations of yeast models for neurodegenerative diseases.
- To highlight the utility of Saccharomyces cerevisiae in disease research.
- To discuss future opportunities using yeast models.
Main Methods:
- Utilizing Saccharomyces cerevisiae as a living model system.
- Employing high-throughput cell-based screens for drug discovery.
- Comparative analysis of yeast models with human disease pathology.
Main Results:
- Yeast models provide significant insights into neurodegenerative disease mechanisms.
- These models facilitate the identification of novel therapeutic targets.
- High-throughput screening in yeast has identified potential therapeutic agents.
Conclusions:
- Saccharomyces cerevisiae models are effective tools for studying neurodegenerative diseases.
- Despite limitations, yeast models offer a powerful platform for therapeutic discovery.
- Future research can expand to other yeast species like Schizosaccharomyces pombe.
More Related Videos
08:24A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
Related Concept Videos
Neural Regulation
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Overview